2.89
+0.01(+0.35%)
Currency In USD
| Previous Close | 2.88 |
| Open | 2.93 |
| Day High | 2.96 |
| Day Low | 2.86 |
| 52-Week High | 8.87 |
| 52-Week Low | 2.37 |
| Volume | 87,475 |
| Average Volume | 501,773 |
| Market Cap | 110.72M |
| PE | -1.63 |
| EPS | -1.77 |
| Moving Average 50 Days | 2.91 |
| Moving Average 200 Days | 4.43 |
| Change | 0.01 |
If you invested $1000 in Orchestra BioMed Holdings, Inc. (OBIO) since IPO date, it would be worth $253.51 as of July 06, 2025 at a share price of $2.89. Whereas If you bought $1000 worth of Orchestra BioMed Holdings, Inc. (OBIO) shares 3 years ago, it would be worth $289.58 as of July 06, 2025 at a share price of $2.89.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Orchestra BioMed Showcases AVIM Therapy as Purpose-Built Solution for Hypertensive Heart Disease at CSI Frankfurt 2025
GlobeNewswire Inc.
Jun 18, 2025 1:30 PM GMT
Presentation underscores unique potential for atrioventricular interval modulation (“AVIM”) therapy to manage blood pressure in older, high-risk patients who have indicators of diastolic dysfunction and progression to heart failure with preserved eje
Orchestra BioMed’s AVIM Therapy Global Intellectual Property Estate Reaches 137 Issued Patents for the Treatment of Hypertension and Heart Failure
GlobeNewswire Inc.
May 07, 2025 12:30 PM GMT
Secured ten new fully-issued patents related to hypertension treatment during last 12 months, bringing global issued patent estate total for this condition to 120 patentsPatent estate covering atrioventricular interval modulation (“AVIM”) therapy now
Orchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated Balloon
GlobeNewswire Inc.
Apr 29, 2025 1:00 PM GMT
Orchestra BioMed’s Virtue® Sirolimus AngioInfusion Balloon™ (“Virtue SAB”) is the only non-coated drug-eluting balloon system under clinical investigation worldwide and has been awarded multiple FDA Breakthrough Device DesignationsThe Virtue Trial wi